Live feed06:00:00·438dPRReleasevia Quantisnow+1GeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025ByQuantisnow·Wall Street's wire, on your screen.BIIB· Biogen Inc.PRAX· Praxis Precision Medicines Inc.STOK· Stoke Therapeutics Inc.WGS· GeneDx Holdings Corp.Health CareTechnology
